THE CHILDREN’S ONCOLOGY DRUG ALLIANCE is joining the research and resources of the University of New South Wales and its commercialization arm, NewSouth Innovations; The Kids’ Cancer Project, an Australia-based childhood cancer research charity; Novogen, an Australian oncology drug development company; and Nationwide Children’s Hospital in Columbus, Ohio, to help accelerate development of a therapeutic approach to neuroblastoma.
To access this subscriber-only content please log in or subscribe.
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe